Status:
RECRUITING
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
Lead Sponsor:
University of Miami
Conditions:
Nephrolithiasis
Urosepsis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.
Eligibility Criteria
Inclusion
- Adults that is able to consent (≥ 18 years of age)
- Scheduled to undergo PCNL at Uhealth tower and Jackson Memorial Hospitals
- not currently immunosuppressed \[White blood count (WBC) \>= 2, not on immunosuppressive medications\]
Exclusion
- unable to consent and \< 18 years of age
- currently immunosuppressed (WBC \< 2, not on immunosuppressive medications)
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04669886
Start Date
November 1 2023
End Date
December 1 2026
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33136